Van der Moeren Nathalie, van den Biggelaar Rik, Gast Karin B, Verweij Jaco J, Bergmans Barbara J M, Stohr Joep J J M, Murk Jean-Luc
Department of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
Department of Medical Microbiology and Immunology, Amphia Hospital, Breda, the Netherlands.
PLoS One. 2025 May 29;20(5):e0322543. doi: 10.1371/journal.pone.0322543. eCollection 2025.
To determine whether combining a SARS-CoV-2 RT-PCR on a fecal sample [FS] with a RT-PCR on an upper respiratory tract sample [URTS] results in additional COVID-19 diagnoses.
We conducted a retrospective observational study at a regional hospital in The Netherlands from 27 February 2020-30 June 2020. Patients presenting with COVID-19-like symptoms for who a SARS-CoV-2 RT-PCR on both URTS and FS were obtained within 24 hours were included. We calculated the difference in positive RT-PCR when combining URTS/FS compared to URTS alone, overall and stratified by symptom duration and disease severity.
Three hundred eighty-six patients were included of which 63 had a positive RT-PCR on URTS [n = 8], FS [n = 19] or both [n = 36], corresponding to a prevalence of 16.3%. The addition of testing FS increased the number of COVID-19 diagnoses by 31.8% [95%CI 20,3%-43,2%].
We showed that adding SARS-CoV-2 RT-PCR on FS to URTS yields significantly more COVID-19 diagnoses. The inclusion of an FS may therefore be considered in patients with a negative URTS and high suspicion of COVID-19.
确定将粪便样本[FS]的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)逆转录聚合酶链反应(RT-PCR)与上呼吸道样本[URTS]的RT-PCR相结合是否能增加新型冠状病毒肺炎(COVID-19)的诊断。
我们于2020年2月27日至2020年6月30日在荷兰一家地区医院进行了一项回顾性观察研究。纳入在24小时内同时获得上呼吸道样本和粪便样本的SARS-CoV-2 RT-PCR检测结果、且表现出COVID-19样症状的患者。我们计算了将上呼吸道样本/粪便样本联合检测与单独检测上呼吸道样本相比,RT-PCR阳性结果的差异,总体情况以及按症状持续时间和疾病严重程度分层后的差异。
共纳入386例患者,其中63例上呼吸道样本[n = 8]、粪便样本[n = 19]或两者[n = 36]的RT-PCR检测结果为阳性,患病率为16.3%。增加粪便样本检测使COVID-19诊断数量增加了31.8%[95%置信区间20.3%-43.2%]。
我们发现,在上呼吸道样本检测基础上增加粪便样本的SARS-CoV-2 RT-PCR检测可显著增加COVID-19的诊断数量。因此,对于上呼吸道样本检测结果为阴性但高度怀疑COVID-19的患者,可考虑增加粪便样本检测。